Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry.
clear-cell ovarian carcinoma
early-stage ovarian carcinoma
endometrioid ovarian carcinoma
histotype-specific prognostic biomarkers
immunohistochemistry
mucinous ovarian carcinoma
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
12
2019
accepted:
29
01
2020
entrez:
6
3
2020
pubmed:
7
3
2020
medline:
7
3
2020
Statut:
epublish
Résumé
Early-stage (I and II) ovarian carcinoma patients generally have good prognosis. Yet, some patients die earlier than expected. Thus, it is important to stratify early-stage patients into risk groups to identify those in need of more aggressive treatment regimens. The prognostic value of 29 histotype-specific biomarkers identified using RNA sequencing was evaluated for early-stage clear-cell (CCC), endometrioid (EC) and mucinous (MC) ovarian carcinomas (
Identifiants
pubmed: 32133296
doi: 10.3389/fonc.2020.00162
pmc: PMC7040170
doi:
Types de publication
Journal Article
Langues
eng
Pagination
162Informations de copyright
Copyright © 2020 Engqvist, Parris, Kovács, Rönnerman, Sundfeldt, Karlsson and Helou.
Références
Biomed Res Int. 2019 Feb 07;2019:6341967
pubmed: 30881993
Oncol Rep. 2019 Jun;41(6):3189-3200
pubmed: 31002363
Mol Biosyst. 2017 Feb 28;13(3):549-555
pubmed: 28102867
Mol Oncol. 2015 Mar;9(3):569-85
pubmed: 25468710
Biochem Pharmacol. 2019 May;163:46-59
pubmed: 30710516
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
Nature. 2006 Nov 30;444(7119):629-32
pubmed: 17108971
PLoS One. 2013 Jul 16;8(7):e68667
pubmed: 23874713
Oncogene. 2017 Sep 21;36(38):5356-5368
pubmed: 28534507
PLoS One. 2018 Feb 16;13(2):e0192881
pubmed: 29451900
J Thorac Dis. 2018 Oct;10(10):5714-5726
pubmed: 30505479
Biochem Biophys Res Commun. 2019 May 28;513(2):340-346
pubmed: 30955858
Sci Rep. 2017 Jun 16;7(1):3673
pubmed: 28623285
Virchows Arch. 2012 Mar;460(3):237-49
pubmed: 22322322
BMC Cancer. 2019 Sep 18;19(1):928
pubmed: 31533654
Nat Rev Cancer. 2009 Oct;9(10):749-58
pubmed: 19776744
Comput Biol Chem. 2008 Dec;32(6):462-8
pubmed: 18757239
Clin Sci (Lond). 2019 Oct 30;133(20):2085-2105
pubmed: 31654063
Biometrics. 2005 Mar;61(1):92-105
pubmed: 15737082
Dig Dis Sci. 2019 Oct;64(10):2878-2892
pubmed: 30949905
Oncol Lett. 2019 Apr;17(4):3851-3861
pubmed: 30930987
Cell Death Dis. 2019 Jan 25;10(2):74
pubmed: 30683849
Cell Res. 2010 Jun;20(6):614-21
pubmed: 20404858
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
pubmed: 16127175
PLoS One. 2014 Nov 17;9(11):e112275
pubmed: 25401743
Int J Biol Sci. 2018 Apr 5;14(5):531-541
pubmed: 29805304
Cell Biosci. 2019 Sep 18;9:75
pubmed: 31548876
PLoS One. 2014 Apr 28;9(4):e95974
pubmed: 24776823
Mol Cell Proteomics. 2008 Oct;7(10):2019-27
pubmed: 18669619
Int J Gynecol Pathol. 2010 May;29(3):203-11
pubmed: 20407318
Am J Surg Pathol. 2020 Feb;44(2):149-161
pubmed: 31498173
Endocr Relat Cancer. 2012 Apr 10;19(2):197-208
pubmed: 22277193
Gynecol Oncol. 2010 Jan;116(1):50-6
pubmed: 19822358
Cell Cycle. 2019 Jul;18(14):1601-1618
pubmed: 31135262
Cancer Res. 2013 Apr 15;73(8):2529-39
pubmed: 23436799
Med Sci Monit. 2018 Jun 08;24:3863-3872
pubmed: 29880787
J Pathol Clin Res. 2018 Oct;4(4):250-261
pubmed: 30062862
Am J Pathol. 2013 Apr;182(4):1391-9
pubmed: 23499052
Cancer Genet. 2019 Jun;235-236:57-64
pubmed: 31078449
Breast Cancer Res Treat. 2007 Mar;101(3):305-15
pubmed: 16821082
Clin Cancer Res. 2004 Nov 1;10(21):7252-9
pubmed: 15534099
Gynecol Oncol. 2019 Sep;154(3):516-523
pubmed: 31340883
Haematologica. 2019 Mar;104(3):576-586
pubmed: 30262568
EMBO J. 2005 Oct 19;24(20):3519-31
pubmed: 16193066
Arch Pathol Lab Med. 1985 Aug;109(8):716-21
pubmed: 3893381
Tumour Biol. 2015 Sep;36(9):6901-8
pubmed: 25851347
Nat Commun. 2019 May 14;10(1):2147
pubmed: 31089132
Nature. 2019 Jan;565(7739):372-376
pubmed: 30626964
J Transl Med. 2014 May 20;12:134
pubmed: 24885308
PLoS Med. 2012;9(5):e1001216
pubmed: 22675273